TransMedics Group, Inc. Deferred Income Tax Expense (Benefit)
TransMedics Group, Inc. (TMDX) reported Deferred Income Tax Expense (Benefit) of $4.87 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-08-04
- TransMedics Group, Inc. deferred income tax expense (benefit) for the quarter ending 2026-06-30 was $3.80M.
- TransMedics Group, Inc. deferred income tax expense (benefit) for the quarter ending 2026-03-31 was $1.07M.
- TransMedics Group, Inc. deferred income tax expense (benefit) for the quarter ending 2023-12-31 was -$120.00K.
- TransMedics Group, Inc. deferred income tax expense (benefit) for fiscal 2025 was -$83.54M.
- TransMedics Group, Inc. deferred income tax expense (benefit) for fiscal 2023 was -$1.66M.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $4.87M 10-Q · filed 2026-08-04 | ||
| 2026-03-31 | $1.07M 10-Q · filed 2026-05-05 | |||
| 2025-12-31 | -$83.54M 10-K · filed 2026-02-24 | |||
| 2023-12-31 | -$120.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$1.66M 10-K · filed 2026-02-24 | ||
| 2023-09-30 | -$1.54M 10-Q · filed 2024-10-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |